BridgeMD
New treatment option for Lung Cancer
Official title Combined Relapse Prediction Model for Resectable Non-Small Cell Patients - a Prospective Clinical Feasibility Trial
ClinicalTrials.gov ID: NCT06262386
What this study is testing
What is Cisplatin based chemottherapy?
Cisplatin based chemottherapy is an investigational medicine, being studied as a potential treatment for lung cancer.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- For patients with lung cancer who have undergone tumor resection, early relapse significantly impacts survival. However, there are currently no reliable screening or imaging tools available to identify patients at risk of early relapse.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 90
You may be able to join if
- Patients who presented with resectable disease ( Clinical stage 1a to 3a)
- Patients who received tumor resection
You likely can't join if
- Pathologic stage greater than stage 3b or 4
- Pathologic stage less than stage 1a1
- Could not complete treatment course
- Could not receive blood sampling for CTC (circulating tumor cell) or regular surveillance
The study team makes the final eligibility decision.
Where it's taking place
- Taoyuan City, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Taoyuan City, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.